Al-Razi Medical Company

SR 22.50As of Sun 8 Nov 2026, 12:00 UTC
Tadawul:9572Healthcare
Country Saudi Arabia
PE (Fwd) •••
TSR 3Y CAGR (13.20%)
Div yield 7.05%
ROE 4.81%
Medical (Pharmaceuticals)
Beta (5Y) 0.41
PE TTM 30.47
TSR TTM (35.34%)
Mkt cap SR 34.20M
ROIC 4.06%
SE Grade™
Value
Quality
Moat
Consensus
Reference
SR 26
13.42%
44.62%
Hold 10|10|12|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per shareSR
0.47
0.52
0.51
0.56
4.46%
13.72%
9.87%
25.89%
RevenueSR M
3.765
3.926
4.034
4.254
10.16%
11.06%
9.42%
18.47%
Peers (US$9.404M)
Cap (US$)
PE
25.99M
33.75x
9.206M
9.006x
Capital
TTM
5Y
10Y
Leveragex
3.110
0.011
0.012
EBIT/Intx
1.006
0.252
0.272
Own earn%
(122.35)
(128.41)
(90.37)
Sh yield%
15.82
52.38
50.76
Owners
Insiders/Inst%
5.11
38.84
Short interest%
4.10
SBC / revenue%
3.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
37–41
$1 testx
0.0
Incr. ROIC%
2